DIRECT DIFFUSION OF CIS-DIAMMINEDICHLOROPLATINUM(II) IN INTRAPERITONEAL RAT-TUMORS AFTER INTRAPERITONAL CHEMOTHERAPY - A COMPARISON WITH SYSTEMIC CHEMOTHERAPY
- 15 June 1989
- journal article
- research article
- Vol. 49 (12) , 3380-3384
Abstract
Chemotherapy, i.p. is increasingly being tested as a treatment modality for cancer limited to the peritoneal cavity. We have developed a rat tumor model in which penetration and distribution of cis-diamminedichloroplatinum(II) into intraperitoneal tumors have been studied. The platinum concentration in intraperitoneal tumor nodules, measured by two techniques, flameless atomic absorption spectroscpy and proton-induced X-ray emission, was always higher after i.p. treatment than i.v. Further, platinum concentrations were higher at the periphery of the tumor after i.p. administration than after i.v., while platinum concentrations in the center of the tumor nodules were identical. No difference was detected in platinum concentrations in s.c. tumors nor in the total area under the curve (plasma) after i.p. and i.v. administration of cis-diamminedichloroplatinum(II), suggesting that the higher drug concentration measured in peritoneal tumors after i.p. administration is due to direct diffusion of the drug from the peritoneal cavity.This publication has 14 references indexed in Scilit:
- Intraperitoneal Chemotherapy with MelphalanAnnals of Internal Medicine, 1984
- Intraperitoneal cytosine arabinoside therapy in ovarian carcinoma.Journal of Clinical Oncology, 1984
- Increased tissue deposition and decreased excretion of platinum following administration of cisplatin to cisplatin-pretreated animalsCancer Chemotherapy and Pharmacology, 1984
- PLASMA PLATINUM LEVELS - RELATIONSHIP TO CISPLATIN DOSE AND NEPHROTOXICITY1983
- Intraperitoneal Cisplatin with Systemic Thiosulfate ProtectionAnnals of Internal Medicine, 1982
- PHASE-1 AND PHARMACOLOGICAL STUDIES OF ADRIAMYCIN ADMINISTERED INTRAPERITONEALLY TO PATIENTS WITH OVARIAN-CANCER1982
- HIGH-VOLUME INTRAPERITONEAL CHEMOTHERAPY WITH METHOTREXATE IN PATIENTS WITH CANCER1981
- PHASE-I AND PHARMACOLOGICAL STUDIES OF 5-FLUOROURACIL ADMINISTERED INTRAPERITONEALLY1980
- PHARMACOKINETICS OF ADRIAMYCIN AND TISSUE PENETRATION IN MURINE OVARIAN-CANCER1979
- PHARMACOKINETIC RATIONALE FOR PERITONEAL DRUG ADMINISTRATION IN TREATMENT OF OVARIAN CANCER1978